{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:25:38Z","timestamp":1778790338673,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP2 \/436\/46"],"award-info":[{"award-number":["RGP2 \/436\/46"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109853","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:00:52Z","timestamp":1775754052000},"page":"109853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Click inspired new series of pyridazine-triazole-persulfonimide derivatives as DPP-4 inhibitors with exploratory HepG2 phenotypic screening"],"prefix":"10.1016","volume":"176","author":[{"given":"Manisha","family":"Nidhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sooraj","family":"Sura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulah Jarboa","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish C.","family":"Chandramoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswathy R.","family":"Devan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekshmi R.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish Kumar","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2026.109853_bb0005","first-page":"S5","article-title":"Diagnosis and classification of diabetes mellitus","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bioorg.2026.109853_bb0010","doi-asserted-by":"crossref","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care, 2009. 32 Suppl 1(Suppl 1): p. S62\u20137.","DOI":"10.2337\/dc09-S062"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109853_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5001\/omj.2012.68","article-title":"Type 2 diabetes mellitus: a review of current trends","volume":"27","author":"Olokoba","year":"2012","journal-title":"Oman Med. J."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109853_bb0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2017.0241","article-title":"Management of type 2 diabetes in 2017: getting to goal","volume":"317","author":"Reusch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2026.109853_bb0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.04.061","article-title":"Current anti-diabetic agents and their molecular targets: a review","volume":"152","author":"Kerru","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109853_bb0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.xkme.2021.07.007","article-title":"Dipeptidyl peptidase-4 inhibitors and diabetic kidney disease: a narrative review","volume":"3","author":"Daza-Arnedo","year":"2021","journal-title":"Kidney Med."},{"key":"10.1016\/j.bioorg.2026.109853_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40200-015-0143-4","article-title":"Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment","volume":"14","author":"Sharma","year":"2015","journal-title":"J. Diabetes Metab. Disord."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109853_bb0040","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109853_bb0045","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/17460441.2022.2129613","article-title":"The 1,2,3-triazole \u2018all-in-one\u2019 ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool","volume":"17","author":"Lengerli","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109853_bb0050","doi-asserted-by":"crossref","DOI":"10.1080\/17518253.2024.2307989","article-title":"Biological importance and synthesis of 1,2,3-triazole derivatives: a review","volume":"17","author":"Vaishnani","year":"2024","journal-title":"Green Chem. Lett. Rev."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109853_bb0055","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres: strategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2026.109853_bb0060","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/cmdc.202000220","article-title":"Structural consequences of the 1,2,3-triazole as an amide bioisostere in analogues of the cystic fibrosis drugs VX-809and VX-770","volume":"15","author":"Doiron","year":"2020","journal-title":"ChemMedChem"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109853_bb0065","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1021\/acs.chemrev.1c00469","article-title":"Introduction: click chemistry","volume":"121","author":"Devaraj","year":"2021","journal-title":"Chem. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109853_bb0070","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/ci500291a","article-title":"Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification","volume":"54","author":"Daga","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109853_bb0075","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1039\/D4MD00481G","article-title":"Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigation","volume":"15","author":"El-Nagar","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109853_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144480","article-title":"Novel hybrid pyridazinone-arylacetamide: synthesis, crystal structure, toxicity, antidiabetic activity, oral starch tolerance test (OSTT), absorption distribution metabolism excretion toxicity (ADMET) and docking studies","volume":"1352","author":"Assila","year":"2026","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109853_bb0085","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2538962","article-title":"Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment","volume":"26","author":"Madkhali","year":"2025","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109853_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020454","article-title":"CD26\/DPP4 as a therapeutic target in nonalcoholic steatohepatitis associated hepatocellular carcinoma","volume":"14","author":"Nishina","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109853_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092191","article-title":"CD26\/DPP-4: type 2 diabetes drug target with potential influence on cancer biology","volume":"13","author":"Kawakita","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109853_bb0100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3350\/cmh.2024.0280","volume":"30","author":"Yiu","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109853_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041148","article-title":"Association of dipeptidyl peptidase-4 inhibitors use with reduced risk of hepatocellular carcinoma in type 2 diabetes patients with chronic HBV infection","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2D","key":"10.1016\/j.bioorg.2026.109853_bb0110","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2023.7118","article-title":"Lower risks of new-onset hepatocellular carcinoma in patients with type 2 diabetes mellitus treated with SGLT2 inhibitors versus DPP4 inhibitors","volume":"22","author":"Chou","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.bioorg.2026.109853_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.711723","article-title":"Dipeptidyl peptidase 4 inhibitors decrease the risk of hepatocellular carcinoma in patients with chronic hepatitis c infection and type 2 diabetes mellitus: a nationwide study in Taiwan","volume":"9","author":"Hsu","year":"2021","journal-title":"Front. Public Health"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109853_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031004","article-title":"Coumarin-based sulfonamide derivatives as potential DPP-IV inhibitors: pre-ADME analysis, toxicity profile, computational analysis, and in vitro enzyme assay","volume":"28","author":"Vawhal","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109853_bb0125","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1039\/D5MA00122F","article-title":"Sorafenib nanocrystals enhance bioavailability and overcome multidrug resistance in liver cancer cells: an approach based on p-gp inhibition strategy","volume":"6","author":"Nasr","year":"2025","journal-title":"Mater. Adv."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109853_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30051043","article-title":"Synthetic approaches to novel DPP-IV inhibitors-a literature review","volume":"30","author":"Petrov","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109853_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115861","article-title":"Synthesis, in vitro evaluation, and computational simulations studies of 1,2,3-triazole analogues as DPP-4 inhibitors","volume":"29","author":"Vo","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109853_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jscs.2012.05.004","article-title":"Synthesis, characterization, antimicrobial and anticancer studies of new steroidal pyrazolines","volume":"20","author":"Shamsuzzaman","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109853_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106750","article-title":"Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as \u03b1-glucosidase inhibitors","volume":"139","author":"Ritu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109853_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105586","article-title":"Click inspired novel pyrazole-triazole-persulfonimide & pyrazole-triazole-aryl derivatives; design, synthesis, DPP-4 inhibitor with potential anti-diabetic agents","volume":"120","author":"Nidhar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109853_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105049","article-title":"Design, synthesis and biological evaluation of glycolamide, glycinamide, and \u03b2-amino carbonyl 1,2,4-triazole derivatives as DPP-4 inhibitors","volume":"114","author":"Fuh","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"122","key":"10.1016\/j.bioorg.2026.109853_bb0160","doi-asserted-by":"crossref","first-page":"100912","DOI":"10.1039\/C5RA19199H","article-title":"Kaempferide, the most active among the four flavonoids isolated and characterized from Chromolaena odorata, induces apoptosis in cervical cancer cells while being pharmacologically safe","volume":"5","author":"Nath","year":"2015","journal-title":"RSC Adv."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109853_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28155860","article-title":"Insight into structure activity relationship of DPP-4 inhibitors for development of antidiabetic agents","volume":"28","author":"Mathur","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109853_bb0170","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s11030-022-10577-4","article-title":"Ligand-based designing of DPP-4 inhibitors via hybridization; synthesis, docking, and biological evaluation of pyridazine-acetohydrazides","volume":"27","author":"Nidhar","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.109853_bb0175","article-title":"Triazole scaffold-based DPP-IV inhibitors for the management of type-II diabetes mellitus: insight into molecular docking and SAR","author":"Shamim","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109853_bb0180","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1080\/07391102.2021.1994876","article-title":"Insights into the structural requirements of triazole derivatives as promising DPP IV inhibitors: computational investigations","volume":"40","author":"Shah","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2026.109853_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129006","article-title":"Computational identification of potential dipeptidyl peptidase (DPP)-IV inhibitors: structure based virtual screening, molecular dynamics simulation and knowledge based SAR studies","volume":"1224","author":"Nath","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"20","key":"10.1016\/j.bioorg.2026.109853_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207708","article-title":"Setup and validation of a reliable docking protocol for the development of neuroprotective agents by targeting the sigma-1 receptor (S1R)","volume":"21","author":"Rossino","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2026.109853_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109853_bb0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","article-title":"Prediction of drug solubility from structure","volume":"54","author":"Jorgensen","year":"2002","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:41:15Z","timestamp":1777452075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S0045206826003895"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109853","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Click inspired new series of pyridazine-triazole-persulfonimide derivatives as DPP-4 inhibitors with exploratory HepG2 phenotypic screening","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109853"}}